Evidence map›Paper›PMID 29796252›Full record

ArticleAntimicrobial resistance and infection control2018

Dynamics of colistin and tobramycin resistance among

M J D Dautzenberg, J R Bayjanov, M A Leverstein-van Hall, A E Muller, L B S Gelinck, C L Jansen, E M S Leyten, T Ruys, J Scharringa, R E van der Starre and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. A genetic cluster of MDRJAC-antimicrobial resistance · 2021
    Article
  5. Clinical microbiology reviews · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M J D Dautzenberg1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
J R Bayjanov1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
M A Leverstein-van HallDepartment of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands.
A E MullerDepartment of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands.
L B S GelinckDepartment of Internal Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands.
C L JansenDepartment of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands.
E M S LeytenDepartment of Internal Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands.
T RuysDepartment of Intensive Care Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands.
J Scharringa1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
R E van der StarreDepartment of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands.
A C Fluit1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
M J M Bonten1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A high prevalence of colistin resistance among Methods: Multi-resistant Results: Colistin-resistant Conclusions: This study demonstrates a stable low-level endemicity of MREb in two Dutch ICUs with prolonged use of SDD, which was characterized by the persistent presence of two clusters, suggesting incidental clonal transmission.

Indexed as

Anti-Bacterial Agentsbeta-Lactam ResistanceColistinDrug Resistance, Multiple, BacterialEnterobacter cloacaeEnterobacteriaceae InfectionsGastrointestinal DiseasesGastrointestinal TractHumansIntensive Care UnitsMicrobial Sensitivity TestsPolymorphism, Single NucleotideProspective StudiesRetrospective StudiesTobramycinWhole Genome SequencingAnti-Bacterial AgentsColistinTobramycinColistin resistanceEnterobacter cloacaeIntensive care unitSelective digestive tract decontaminationTobramycin resistance

Identifiers

PMID29796252
PMCPMC5964641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.